| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |